Australia markets closed

Sino Biopharmaceutical Limited (SBHMY)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
6.780.00 (0.00%)
At close: 01:45PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.42B
Enterprise value 6.21B
Trailing P/E 23.80
Forward P/E 22.03
PEG ratio (5-yr expected) 1.31
Price/sales (ttm)1.72
Price/book (mrq)1.50
Enterprise value/revenue 1.72
Enterprise value/EBITDA 6.47

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 3-30.53%
S&P500 52-week change 322.55%
52-week high 39.63
52-week low 36.68
50-day moving average 37.16
200-day moving average 37.93

Share statistics

Avg vol (3-month) 3113
Avg vol (10-day) 340
Shares outstanding 5939.56M
Implied shares outstanding 6957.57M
Float 89.28B
% held by insiders 10.00%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.28
Forward annual dividend yield 44.21%
Trailing annual dividend rate 30.05
Trailing annual dividend yield 30.66%
5-year average dividend yield 41.67
Payout ratio 472.83%
Dividend date 313 Nov 2023
Ex-dividend date 412 June 2024
Last split factor 21.5:1
Last split date 314 Aug 2020

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 8.90%
Operating margin (ttm)20.76%

Management effectiveness

Return on assets (ttm)5.33%
Return on equity (ttm)12.12%

Income statement

Revenue (ttm)26.2B
Revenue per share (ttm)28.28
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA 6.38B
Net income avi to common (ttm)1.85B
Diluted EPS (ttm)0.28
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.12B
Total cash per share (mrq)0.77
Total debt (mrq)12.72B
Total debt/equity (mrq)33.31%
Current ratio (mrq)1.05
Book value per share (mrq)1.66

Cash flow statement

Operating cash flow (ttm)6.07B
Levered free cash flow (ttm)3.01B